Similar Articles |
|
Managed Care March 2007 Louis W. Hutchison |
Unable to Carry Cost Burden, Payers Seek Other Remedies The pharmacy benefit landscape of today is all but unrecognizable from its predecessor of just a decade ago. Blending an approach that uses education, reward, and penalty can rein in runaway health care costs |
Managed Care January 2004 |
Study: Loosening of Managed Care Hurts the Poor The retreat from tightly managed health care in recent years has left casualties on the insurance battlefield: people with low incomes and chronic illness. |
Managed Care December 2003 MargaretAnn Cross |
Will New Benefit Design Harm Some Patients? In the past, reducing demand for care by raising patients' costs has resulted in the loss of some needed care. Can we avoid the trap? |
Managed Care September 2001 |
Wide variation in pharmacy utilization On a per-capita basis, prescription drug use in the U.S. is generally highest in the South and Midwest, and lowest in four states with high managed care penetration -- California, Massachusetts, Colorado, and New York... |
Managed Care January 2008 |
The Formulary Files A look at the factors that affect formulary switching. |
Managed Care August 2004 Martin Sipkoff |
Bad Tiered Formulary Designs Yield Poor Outcomes, High Cost Now that tiered formularies rule the land, what many suspected is being demonstrated: Compliance is suffering and so, too, are patients. |
Managed Care November 2006 |
The Formulary Files Step therapy for antidepressants saves 11.7 percent in one year. |
Managed Care July 2006 |
Specialty Anti-Inflammatories See Huge Increase in Utilization Americans spent 34% more for specialty anti-inflammatory agents used to treat rheumatoid arthritis in 2005 than any other specialty drug category. |
Pharmaceutical Executive May 1, 2011 Mason Tenaglia |
Out of Control The pharmaceutical industry needs to use new and better data to accurately measure how much it is willing to invest in avoiding plan control. |
Managed Care May 2003 Wayne Miller |
Higher Drug Copays Now Might Cause Problems Later The long-term impact of noncompliance must be considered before copayments are increased. This is especially true where chronic conditions are concerned. |
Managed Care July 2002 Thomas Kaye |
Managing the Drug Benefit: One Company's Experience The pharmacy director of Blue Cross of Oklahoma shares his company's success with using three tiers and coinsurance to promote member responsibility. |
Managed Care April 2006 Martin Sipkoff |
Blues Plan's Bold Move Brings Generics Savings Blue Cross & Blue Shield of North Carolina is waiving its copayments for generic drugs in a unique six-month pilot program. |
Managed Care February 2007 |
Study: Copayments do Affect Compliance Managed care decision makers have a powerful tool that affects patient compliance with antihypertensive medications - the copayment level. |
Managed Care March 2008 |
Drug Caps Lower Spending, but .... These policies tend to make consumers shoulder some of the cost of prescriptions and the cost could be a barrier to medication adherence. |
Managed Care October 2001 |
Small businesses use aggressive tactics to keep benefit costs down Small and mid-sized employers (10-999 workers) saw average health-benefit-premium increases of 9.2 percent last year. Marsh Inc. reports that these companies aggressively blunted the effects of fast-rising health care costs... |
Managed Care June 2002 Berg & Wadhwa |
Diabetes Disease Management in a Community-Based Setting This study strongly suggests that the implementation of such a program is associated with positive behavioral change and substantial reduction in medical-service utilization. |
The Motley Fool January 19, 2010 Matt Koppenheffer |
The Energy Bulls May Be Right Could a recent Fed report signal even better times for energy companies? |
Managed Care October 2004 Martin Sipkoff |
Not So Much of a Reach: Let Sick Pay Less for Drugs The idea is radical and simple: Those who need medication the most should pay the least. There is evidence that this is cost-effective. |